Hei, du må oppdatere nettleseren din for å kunne besøke oss.
logo Helse Bergen

Bergen Translational Cardiac Research Group

Dept. of Heart Disease Haukeland University Hospital

Coronary artery disease is the leading cause of death in the world, and heart disease imposes a heavy burden on patients, society and the health care system. Main paths for improvement of cardiovascular health include strategies for optimized prevention, diagnosis and treatment through novel biomarkers, imaging techniques and

experimental and clinical intervention protocols. 

The current research program focuses on unsolved and new aspects along the atherosclerotic line: integrating preclinical discovery of possible new causative factors of atherosclerosis, early identification of sublinical cardiovascular disease and finally improved diagnostics and treatment of stable and acute heart disease.
The current research program intends to deliver high quality cardiovascular research using novel biomarkers, coronary computed tomography angiography, cardiac magnetic resonance imaging and cardiac ultrasound. Further, the program uses a translational research approach to introduce novel interventions and medical devices in the diseased heart and better percutaneous and surgical treatment in patients with heart disease.
 
The current research program was made possible through a generous gift from Trond Mohn Foundation of 15 MNOK.

En gruppe mennesker som poserer for et bilde
Core member of the research group.

 

Core member of the research group

  • Co-PI and PI of the BACIO study: Associate professor Kristin M Aakre, MD, PhD and Professor Torbjørn Omland, MD, PhD, MPH
  • Director, Department of Heart Disease, Associate professor Kjell Vikenes, MD, PhD
  • PI and Co-PI of the Experimental study: Associate professor Stig Urheim, MD, PhD and Associate professor Vegard Tuseth, MD, PhD

BACIO study:

PI: Torbjørn Omland, MD, PhD, MPH, FESC, FACC
Professor of Medicine, University of Oslo
Department of Cardiology, Akershus University Hospital, Norway
Associate Editor Circulation
Mobile phone: +47 40107050
e-mail: torbjorn.omland@medisin.uio.no

Co-PI: Kristin Moberg Aakre, MD, PhD
Associate professor, University of Bergen
Consultant, Department of Medical Biochemistry and Pharmacology & Department of Heart Disease
Haukeland University Hospital
NO-5021 Bergen, Norway
Tel: 47 55973188
e-mail: kristin.moberg.aakre@helse-bergen.no


Experimental study:

PI: Stig Urheim, MD, PhD
Associate professor, University of Bergen
Consultant, Department of Heart Disease
Haukeland University Hospital
NO-5021 Bergen, Norway
Tel: +47 55976755
e-mail: stig.urheim@helse-bergen.no

Co-Pi: Vegard Tuseth, MD, PhD
Associate professor, University of Bergen
Consultant, Department of Heart Disease
Haukeland University Hospital
NO-5021 Bergen, Norway
Tel: +4790151148
e-mail: vegard.tuseth@helse-bergen.no

Maŋemus ođastuvvon 2024-01-02